Drug Profile
Research programme: koningic acid esters - TMS
Alternative Names: KA estersLatest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator TMS
- Class Antineoplastics; Sesquiterpenes
- Mechanism of Action Glyceraldehyde 3 phosphate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Cancer in Japan
- 04 Aug 2016 Early research in Cancer in Japan (unspecified route)